NCT04228640View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of Uthever NMN(Nicotinamide Mononucleotide, a Form of Vitamin B3)

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

February 27, 2021

Study Completion Date

March 30, 2021

Conditions
Aging
Interventions
OTHER

NMN

Investigational Product

OTHER

Placebo

Starch Powder

Trial Locations (2)

411019

Dr Kamalakar Gajarae, Pune

411030

Swasthiye Clinic and Research Center, Pune

Sponsors

Collaborators (1)

ProRelix Research
All Listed Sponsors
collaborator

ProRelix Research

INDUSTRY

lead

EffePharm LTD

INDUSTRY